MIM
TNDM icon

Monashee Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Monashee Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Hold
0
– – – 78
2015
Q2 		– Sell
-6,800
Closed -$858K – 92
2015
Q1 		$858K Buy
+6,800
New +$884K 0.53% 50

Other funds holding TNDM

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Monashee Investment Management's TNDM Position: Q1 2017 in Review

Monashee Investment Management held its Tandem Diabetes Care (TNDM) position steady in Q1 2017 at 0 shares worth $180K. The position accounts for 0.07% of the portfolio, ranked #78.

Monashee Investment Management first reported a position in TNDM in Q1 2015 and has held it in 1 quarter since. The position peaked at $858K in Q1 2015. 80 funds tracked by Wall St. Rank hold TNDM as of Q1 2017.

  • Monashee Investment Management held 0 shares of Tandem Diabetes Care worth $180K as of Q1 2017.
  • Monashee Investment Management left its Tandem Diabetes Care share count unchanged in Q1 2017.
  • Tandem Diabetes Care made up 0.07% of Monashee Investment Management's portfolio in Q1 2017, its #78 holding.
  • Monashee Investment Management first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 1 quarter since.
  • Monashee Investment Management's Tandem Diabetes Care position peaked at $858K in Q1 2015.
  • 80 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2017.

Based on Monashee Investment Management's 13F filing for Q1 2017, filed 12 May 2017.